Oncology News

A new urine-based test for men with prostate cancer can distinguish the slow-growing form of the disease from the more aggressive type that would require immediate treatment, according to study data published in JAMA Oncology.

Breast cancer survivors aged 40 years or younger without pathogenic variants had a low second primary breast cancer diagnosis risk in the first 10 years after initial cancer diagnosis, researchers reported in JAMA Oncology.

In this episode, host Shikha Jain, MD, speaks with Jonathan D. Licht, MD, about becoming and training qualified leaders in the field, challenges facing health care leaders and more.

In this edition, durvalumab improves survival in limited-stage small cell lung cancer, most adults do not test homes for radon exposure and more.

Most adults have not tested their homes for radon, nor have they taken action to reduce radon exposure despite its link to cancer, a survey showed.

Only 30% of women with health-related social needs underwent mammography screening for breast cancer in the previous 2 years, according to a newly released CDC Vital Signs report.

Many young women with newly diagnosed breast cancer have concerns regarding fertility, and these concerns may impact their treatment decisions, according to study findings published in Cancer Medicine.

Socioecological factors may explain the disproportionate impact of aggressive breast tumor phenotypes for racial and ethnic minority women, according to study results published in JAMA Network Open.

In this episode, host Shikha Jain, MD, speaks with Aparna Parikh, MD, about cancer and GI malignancies in the global health space, circulating tumor DNA in the field of oncology and more.

A quality performance measure that tracks follow-up colonoscopy rates within 6 months of an abnormal stool-based screening test was feasible and had a median reliability of 94.5% across health care organizations, according to researchers.